[Recessive optic neuritis during lucitis due to Mederel].
D003875:Drug Eruptions / Q000517:prevention & control; D005707:Gallic Acid / Q000009:adverse effects / Q000378:metabolism; D006801:Humans; D007659:Ketones / Q000009:adverse effects / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000627:therapeutic use; D009902:Optic Neuritis / Q000139:chemically induced* / Q000150:complications / Q000517:prevention & control; D010078:Oxazines / Q000009:adverse effects* / Q000378:metabolism; D011736:Pyridoxine / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000009:adverse effects*
D007659:Ketones; D010078:Oxazines; D014665:Vasodilator Agents; D009536:Niacinamide; D005707:Gallic Acid; D011736:Pyridoxine
Névrites optiques récessives au cours des lucites au Médérel.